C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2009
10/21/2009	EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009	EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009	EP1392359B1 Specific binding proteins and uses thereof
10/21/2009	EP1292680B1 Agonist anti-trk-c monoclonal antibodies
10/21/2009	EP1117672B1 Antisense modulation of survivin expression
10/21/2009	EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009	EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009	CN101563466A Modified release amoxicillin products
10/21/2009	CN101563362A Recombinant HCV E2 glycoprotein
10/21/2009	CN101563101A Methods and compositions for stabilizing prostate specific antigen
10/21/2009	CN101560513A Trichoderma reesei expression cassette, recombinant strain and application thereof
10/21/2009	CN101560506A Process for preparing catalase and hepatocyte growth-promoting decoction simultaneously by taking animal liver as raw material
10/21/2009	CN101560475A Uracil auxotroph Hansenula yeast, construction method thereof and application thereof
10/21/2009	CN101560473A Strain with high destruxins yield and application thereof
10/21/2009	CN101560257A Heavy metal copper monoclonal antibody and preparation method thereof
10/21/2009	CN101560255A Anti-rabies virus monoclonal antibody and preparation method and application
10/21/2009	CN100552023C Aminopeptidase
10/20/2009	USRE40940 DNA sequences from the K. lactis PGK gene having transcriptional promoter activity; expression vectors comprising these sequences and to their use for the production of proteins
10/20/2009	US7605246 Genes differentially expressed in breast cancer
10/20/2009	US7605245 PUFA polyketide synthase systems and uses thereof
10/20/2009	US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009	US7605235 Immunoglobulins; Fc receptors; improved antibody-dependent cell mediated cytotoxicity (ADCC); cancer; transgenic animals; host cells
10/20/2009	US7605233 Tumour necrosis factor binding ligands
10/20/2009	US7605226 Meltrins
10/20/2009	US7605000 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
10/20/2009	US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
10/20/2009	US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus
10/20/2009	US7604969 improved substrate specificity to glucose, amino acid sequence having the substitution, deletion, insertion or addition of one or more amino acid residues excluding amino acid 365 in the amino acid sequence
10/20/2009	US7604960 Transient protein expression methods
10/20/2009	US7604958 Transfection, culturing; electrophoresis
10/20/2009	US7604810 Conserved Neisserial antigens
10/20/2009	CA2359667C Method of identifying n-terminal probnp
10/20/2009	CA2330363C Diacylglycerol o-acyltransferase
10/20/2009	CA2330183C Novel insulin analogs with enhanced zinc binding
10/20/2009	CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/15/2009	WO2009126623A2 Expression of heterologous sequences
10/15/2009	WO2009126564A1 Methods of recombinant production of glycoproteins
10/15/2009	WO2009125831A1 Monoclonal antibody directed against nk4
10/15/2009	WO2009125825A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
10/15/2009	WO2009125343A2 Method for producing selenoproteins
10/15/2009	WO2009124381A1 An anti-cancer cytotoxic monoclonal antibody
10/15/2009	WO2009124378A1 Chimeric anti-measles antibody
10/15/2009	WO2009105671A3 Methods and compositions related to peptides and proteins with c-terminal elements
10/15/2009	WO2008140477A9 Hybrid immunoglobulins with moving parts
10/15/2009	WO2008131094A8 Method for controlling glucose uptake and insulin sensitivity
10/15/2009	US20090259035 Method for producing recombinant RNase A
10/15/2009	US20090259026 Ligand
10/15/2009	US20090259019 Masp-2, a complement fixing enzyme, and uses for it
10/15/2009	US20090259018 Protein consentrate from starch containing grains: composition, method of making, and uses thereof
10/15/2009	US20090258954 Protective hydrocolloid for active ingredients
10/15/2009	US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009	US20090258409 Purified sr-p70 protein
10/15/2009	US20090258396 Crustaceans as production systems for therapeutic proteins
10/15/2009	US20090258395 Irx-2 modified manufacturing process
10/15/2009	US20090258394 Method for the production of high-level soluble human recombinant interferon alpha in e. coli and vectors useful for such a production
10/15/2009	US20090258393 Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
10/15/2009	US20090258392 Sequence diversity generation in immunoglobulins
10/15/2009	US20090258391 Recombinant cell clones having increased stability and methods of making and using same
10/15/2009	US20090258390 Prokaryotic collagen-like proteins and uses thereof
10/15/2009	US20090258389 Construction of New Variants of Dextransucrase DSR-S by Genetic Engineering
10/15/2009	US20090258388 Methods of enhanced heterologous protein secretion
10/15/2009	US20090258387 Bioactive whey protein hydrolysate
10/15/2009	US20090258357 identifying a binding partner to a cytokine receptor common gamma chain like (CRCGCL) polypeptide encoded by a cDNA; for diagnosis and treatment autoimmune disorders
10/15/2009	US20090258031 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response
10/15/2009	US20090258026 Anti-notch1 nrr antibodies and methods using same
10/15/2009	US20090258023 Tgf-beta superfamily binding proteins and modulation of bone formation and loss
10/15/2009	US20090258022 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
10/15/2009	US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009	US20090258008 Uses of the FcRn Receptor
10/15/2009	US20090258007 Anti-Perp Antibody
10/15/2009	US20090258005 Therapeutic compositions and methods
10/15/2009	US20090256068 Solution fragmentation systems and processes for proteomics analysis
10/15/2009	CA2721052A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
10/15/2009	CA2720610A1 Methods of recombinant production of glycoproteins
10/14/2009	EP2108707A2 Molecular identification of Aspergillus Species
10/14/2009	EP2108697A1 Improved methods of in vitro protein systhesis
10/14/2009	EP1558747B1 Glycoprotein synthesis
10/14/2009	EP1539948B1 Improved methods of in vitro protein synthesis
10/14/2009	EP1392835B1 Expression vector using for animal cell
10/14/2009	EP1356046B1 Cytokine receptor zcytor19
10/14/2009	EP1339750B1 Process for selecting anti-angiogenesis antibody fragments
10/14/2009	EP1304375B1 Method of preparing antibody by gene immunization
10/14/2009	EP1161548B2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/14/2009	EP1005481B1 Methods for the production of aslv reverse transcriptases composed of multiple subunits
10/14/2009	CN101555512A Preparation method for monoclonal antibody specifically binding vardenafil and analog thereof
10/14/2009	CN101555485A Non-fusion expression of recombinant human parathyroid hormone (1-84) and large-scale preparation method
10/14/2009	CN101555484A Recombinant human HMBOX1 expression vector, expression production thereof and antibody and application thereof
10/14/2009	CN101555479A Moss expressing promoting regions
10/14/2009	CN101555477A Heavy and light chain variable region gene of monoclonal antibody resisting human amyloid
10/14/2009	CN100549174C Recombinant human ciliary nerve trophic factor mutant and method for preparing same
10/14/2009	CN100549169C Expression of recombinant proteinase K from tritirachium album in yeast
10/13/2009	US7601891 Optimizing glycan processing of a plant cell containing glycoproteins with hybrid or complex type N-glycanscontaining a galactose residue on one arm of the N-glycan and which are devoid or reduced in xylose and fucose residues; genetic engineering; hybrid enzymes; drugs
10/13/2009	US7601888 Nucleic acid constructs and methods for producing altered seed oil compositions
10/13/2009	US7601818 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
10/13/2009	US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009	US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009	US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy
10/13/2009	US7601813 Anti-GL50 antibodies
10/13/2009	US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009	US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs

1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1125